Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04066491
Status:
TERMINATED
Last Update Posted:
2023-11-14
First Post:
2019-08-22
Brief Title:
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa M7824 in Participants With 1L BTC
Sponsor:
EMD Serono Research Development Institute Inc
Organization:
EMD Serono
Organization Data
Organization:
EMD Serono
Class:
INDUSTRY
Study ID:
MS200647_0055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
EMD Serono Research Development Institute Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck KGaA Darmstadt Germany | INDUSTRY |